ChatDocto
Find a doctor
White scored tablet

ALPRESS LP 5 mg

Prazosine · prolonged-release tablets

B/30Oral use
20,982 DTRecorded public price · B/30
See all pack prices
Strength5 mg
Therapeutic classSYSTEME CARDIOVASCULAIRE
ATC codeC02CA01

About this medicine

ALPRESS LP 5 mg prolonged-release tablets is listed in Tunisia's medicine catalog under the active ingredient Prazosine. This page brings together its recorded pack formats, prices and CNAM coverage information.

What is this medicine used for?

Review pending

A reviewed explanation of uses is not yet published for this medicine in this language. Ask a pharmacist for the leaflet for your exact product.

What side effects should I know about?

Review pending

A reviewed side-effect guide is not yet published for this medicine in this language. This does not mean that the medicine has no side effects. Read your product leaflet or ask a pharmacist.

Price by pack

Compare the recorded price for each exact pack. A catalog entry does not confirm pharmacy stock.

  • Pack · B/30

    30 units in this pack

    Recorded public price20,982 DT
    AMM No.
    6043042
    CNAM code
    105086
    CNAM reference amount
    20,970 DT

    Price source: CNAM — Liste des médicaments remboursables · 2026-08-04

    Source recorded: August 23, 2026

    Price effective date not provided

This reference amount is not a guaranteed refund or a personal out-of-pocket estimate. Your coverage conditions must be confirmed separately.

Medicine details

Dosage formprolonged-release tablets
Route of administrationOral use
LaboratoryPFIZER HOLDING FRANCE
OriginOriginator
ScheduleA
ATC codeC02CA01 — Prazosine
Therapeutic classSYSTEME CARDIOVASCULAIRE